Yazar "Yilmaz, M. B." seçeneğine göre listele
Listeleniyor 1 - 16 / 16
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Comparison of outcome in systolic heart failure patients using ivabradine, digoxin or neither of them: a real life study(Wiley, 2017) Ural, D.; Mutluer, F. O.; Kaya, H.; Beton, O.; Cavusoglu, Y.; Temizhan, A.; Guvenc, T. S.; Gungor, H.; Ege, M. Refiker; Zoghi, M.; Karauzum, K.; Altay, H.; Yilmaz, M. B.Öğe DATA ON SMOKING IN TURKEY: SYSTEMATIC REVIEW, META-ANALYSIS AND META-REGRESSION OF EPIDEMIOLOGICAL STUDIES ON CARDIOVASCULAR RISK FACTORS(Elsevier Ireland Ltd, 2019) Ozer, N.; Kilickap, M.; Tokgozoglu, L.; Goksuluk, H.; Karaaslan, D.; Kayikcioglu, M.; Yilmaz, M. B.; Barcin, C.; Abaci, A.; Sahin, M.Öğe Decrease in prevalence of hypertension in 15 years: a success story of a population through salt reduction initiatives(Oxford Univ Press, 2018) Kilickap, M.; Barcin, C.; Goksuluk, H.; Karaaslan, D.; Ozer, N.; Kayikcioglu, M.; Ural, D.; Yilmaz, M. B.; Abaci, A.; Tokgozoglu, L.Öğe DISTRIBUTION OF CARDIOVASCULAR RISK AMONG PATIENTS WITH DYSLIPIDEMIA IN TURKEY: RESULTS FROM A DELPHI PANEL(Elsevier Ireland Ltd, 2022) Yilmaz, M. B.; Cinar, O.; Gungor, B.; Kayikcioglu, M.; Oz, T. K.; Ozdogan, O.; Sinan, U. Y.[No Abstract Available]Öğe The effect of genetic polymorphism on the dose and tlerability to beta-blocker therapy in turkish heart failure population(Wiley-Blackwell, 2015) Zoghi, M. Mehdi; Yilmaz, M. B.; Cavusoglu, Y.; Aykut, A.; Onay, H.; Ergene, O.Öğe The effect of genetic polymorphism on the dose and tlerability to beta-blocker therapy in turkish heart failure population(Wiley-Blackwell, 2015) Zoghi, M. Mehdi; Yilmaz, M. B.; Cavusoglu, Y.; Aykut, A.; Onay, H.; Ergene, O.Öğe The effect of genetic polymorphism on the dose and tlerability to beta-blocker therapy in turkish heart failure population(Wiley-Blackwell, 2015) Zoghi, M. Mehdi; Yilmaz, M. B.; Cavusoglu, Y.; Aykut, A.; Onay, H.; Ergene, O.Öğe Gaps in management among HFREF outpatients with diabetes mellitus(Wiley-Blackwell, 2015) Kaya, H. Hakki; Yagmur, B.; Acar, B.; Demir, M.; Eraslan, S.; Karauzum, K.; Ege, M.; Acar, G.; Celik, A.; Yilmaz, M. B.Öğe Gaps in management among HFREF outpatients with diabetes mellitus(Wiley-Blackwell, 2015) Kaya, H. Hakki; Yagmur, B.; Acar, B.; Demir, M.; Eraslan, S.; Karauzum, K.; Ege, M.; Acar, G.; Celik, A.; Yilmaz, M. B.Öğe Gaps in management among HFREF outpatients with diabetes mellitus(Wiley-Blackwell, 2015) Kaya, H. Hakki; Yagmur, B.; Acar, B.; Demir, M.; Eraslan, S.; Karauzum, K.; Ege, M.; Acar, G.; Celik, A.; Yilmaz, M. B.Öğe Influence of influenza vaccination on recurrent hospitalization in patients with heart failure(Urban & Vogel, 2017) Kaya, H.; Beton, O.; Acar, G.; Temizhan, A.; Cavusoglu, Y.; Guray, U.; Zoghi, M.; Ural, D.; Ekmekci, A.; Gungor, H.; Sari, I.; Oguz, D.; Yucel, H.; Zorlu, A.; Yilmaz, M. B.The current study aimed to evaluate the influence of regular annual influenza vaccinations on cardiovascular (CV) death and heart failure-related hospitalizations (HFrH) in stable outpatients with heart failure with reduced ejection fraction. The Turkish research team-HF (TREAT-HF) is a network undertaking multicenter, observational cohort studies in HF. This study is a subgroup analysis of TREAT-HF outpatient cohorts who completed a questionnaire on influenza vaccination status and for whom follow-up data were available. A total of 656 patients with available follow-up data for CV death and HFrH including recurrent hospitalization were included in the study. Patients were classified into two groups: those who received regular influenza vaccination (40 %) and those who did not receive vaccination. During a mean follow-up of 15 +/- 6 months, 113 (18 %) patients had CV death and 471 (72 %) patients had at least one HFrH. The CV death rate was similar in both groups of patients (16 vs. 19 %, p = 0.37), whereas, HFrH and recurrent HFrH were significantly less frequently encountered in patients who received regular influenza vaccination than in those who did not receive vaccination (43 vs. 92 % and 16 vs. 66 %, p < 0.001, respectively). In a multivariate Cox proportional hazards model - in addition to a few clinical factors - vaccination status (HR = 0.30, 95 % CI = 0.17-0.51, p < 0.001) and graduation from university (HR = 0.35, 95 % CI = 0.17-0.72, p = 0.004) remained independently associated with the risk of recurrent HFrH. Regular influenza vaccination does not influence CV deaths; however, it decreases HFrH including recurrent episodes of HFrH in outpatients with heart failure with reduced ejection fraction.Öğe MANAGEMENT OF PATIENTS WITH LDL-CHOLESTEROL LEVELS > 190MG/DL (4.9MMOL/L) IN TURKEY: AN ANALYSIS BASED ON DELPHI PANEL APPROACH(Elsevier Ireland Ltd, 2022) Kayikcioglu, M.; Yuksel, U. C.; Yilmaz, M. B.; Temizhan, A.; Sinan, U. Y.; Ozdogan, O.; Oz, T. K.[No Abstract Available]Öğe MANAGEMENT OF SECONDARY PREVENTION PATIENTS WITH LDL-CHOLESTEROL LEVELS < 70MG/DL (1.8MMOL/L): AN ANALYSIS BASED ON DELPHI PANEL APPROACH(Elsevier Ireland Ltd, 2022) Kayikcioglu, M.; Temizhan, A.; Gungor, B.; Yilmaz, M. B.; Ozdogan, O.; Cinar, O.; Oz, T. K.[No Abstract Available]Öğe Presence of accompanying diabetes mellitus is associated with preserved right heart functions among HFREF outpatients(Wiley-Blackwell, 2015) Kaya, H. Hakki; Yagmur, B.; Acar, B.; Demir, M.; Eraslan, S.; Karauzum, K.; Oguz, D.; Acar, G.; Celik, A.; Yilmaz, M. B.Öğe Presence of accompanying diabetes mellitus is associated with preserved right heart functions among HFREF outpatients(Wiley-Blackwell, 2015) Kaya, H. Hakki; Yagmur, B.; Acar, B.; Demir, M.; Eraslan, S.; Karauzum, K.; Oguz, D.; Acar, G.; Celik, A.; Yilmaz, M. B.Öğe Presence of accompanying diabetes mellitus is associated with preserved right heart functions among HFREF outpatients(Wiley-Blackwell, 2015) Kaya, H. Hakki; Yagmur, B.; Acar, B.; Demir, M.; Eraslan, S.; Karauzum, K.; Oguz, D.; Acar, G.; Celik, A.; Yilmaz, M. B.